Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | THRA | P10827 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4931798 | 0.90 | THRB (0.41) | FFAR1THRBTHRA | |
| SCHEMBL4931768 | 0.90 | FFAR1 (0.40) | FFAR1MRGPRX4MAPTKMT2ASLC7A5 | |
| SCHEMBL5112370 | 0.89 | FFAR1 (0.39) | FFAR1LMNAMRGPRX4MAPTMEN1 | |
| SCHEMBL4922903 | 0.89 | FFAR1 (0.39) | FFAR1LMNAMRGPRX4MAPTMEN1 | |
| SCHEMBL4926575 | 0.89 | FFAR1 (0.39) | FFAR1LMNAMRGPRX4MAPTMEN1 | |
| SCHEMBL4933984 | 0.88 | FFAR1 (0.39) | FFAR1LMNAMRGPRX4MAPTMEN1 | |
| SCHEMBL5119830 | 0.87 | TSHR (0.40) | FFAR1LMNAMRGPRX4MAPTMEN1 | |
| SCHEMBL5116056 | 0.87 | PTGER1 (0.38) | FFAR1LMNAMRGPRX4MAPTMEN1 | |
| SCHEMBL5107563 | 0.87 | FFAR1 (0.38) | FFAR1LMNAMRGPRX4MAPTMEN1 | |
| SCHEMBL4931731 | 0.87 | MRGPRX4 (0.40) | FFAR1MRGPRX4KMT2AFFAR4THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221210-A1 | Thyroid Receptor Agonists | KARO BIO AB (SE) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221210-A1 | Thyroid Receptor Agonists | TSHR, TRHR, THRA | FFAR1 37/4885LMNA 3893/4885MRGPRX4 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.